Search results
Results from the WOW.Com Content Network
The DrugBank Online website is available to the public as a free-to-access resource. However, use and re-distribution of content from DrugBank Online or the underlying DrugBank Data, in whole or part, and for any purpose requires a license. Academic users can apply for a free license for certain use cases while all other users require a paid ...
The IUPHAR/BPS Guide to PHARMACOLOGY is an open-access website, acting as a portal to information on the biological targets of licensed drugs and other small molecules. The Guide to PHARMACOLOGY (with GtoPdb being the standard abbreviation) is developed as a joint venture between the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS).
The Government of the Philippines together with the Department of Transportation and Metro Rail Transit Corporation will win bidding process for the MRT Line 3 South Extension Project with stations Roxas Boulevard station and Diokno Boulevard station with construction which is slated to begin in the 2nd quarter of 2026.
The term login comes from the verb (to) log in and by analogy with the verb to clock in. Computer systems keep a log of users' access to the system. The term "log" comes from the chip log which was historically used to record distance traveled at sea and was recorded in a ship's log or logbook.
In October 2024, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Wainzua, intended for the treatment of adults with hereditary transthyretin-mediated amyloidosis (ATTRv) and stage 1 or 2 polyneuropathy. [11]
These are term-limited and retiring members of the House of Representatives of the Philippines during the 19th Congress of the Philippines, who either cannot or chose not to run in the 2025 House elections. In the Philippines, members of the House of Representatives are limited to three consecutive terms.
Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as atopic dermatitis (eczema), asthma and nasal polyps which result in chronic sinusitis.
As of 17 April 2020, the application is still under review at the other agencies. [9] Tucatinib is a kinase inhibitor meaning it blocks a type of enzyme (kinase) and helps prevent the cancer cells from growing. [9] Tucatinib is approved for treatment after adults have taken one or more anti-HER2-based regimens in the metastatic setting. [9]